Politics Lev Facher In a pivotal race in North Carolina, Democrats try to paint the incumbent as ‘pharma’s favorite senator’
Pharmalot Ed Silverman Pharma cost watchdog, with fresh backing, will issue reports on ‘unjustified price hikes’
Pharmalot Ed Silverman Pharmalittle: Hikma makes big price hikes; controversy over Glaxo hepatitis B vaccine supplies
Pharmalot Ed Silverman Pharmalittle: GSK looks to sell antibiotics unit; China wins big price cuts on drugs
First Opinion James R. Baker Jr. EpiPen pricing controversy reflects larger issues in pharma industry
Health Andrew Joseph Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision
First Opinion Ed Schoonveld If 2021 is to be the year of U.S. drug price controls, how should biopharma companies respond?
First Opinion Michael Mandel The ‘prescription escalator’ may be to blame for rising out-of-pocket drug spending
Politics Lev Facher and Nicholas Florko Sensing an advantage, Democrats dare Trump to talk drug prices during State of the Union
Pharmalot Ed Silverman Pharmalittle: Judge orders pause in suits against Purdue and Sacklers; Teva must face opioid trial
Pharmalot Ed Silverman Doctors Without Borders demands drug makers lower their prices for TB treatments
Politics Lev Facher and Nicholas Florko Senate committee unveils ambitious plan to cap drug price hikes, out-of-pocket expenses
Pharmalot Ed Silverman Pharmalittle: Opioid companies failed to halt suspicious orders; U.K. diabetics are rationing insulin
Pharmalot Ed Silverman Pharmalittle: Roche hits milestone with personalized cancer drug; data on a fountain of youth drug
Pharmalot Ed Silverman Baltimore sues a J&J unit over ‘sham’ patent litigation to extend its monopoly on a cancer drug
Pharmalot Ed Silverman Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says
First Opinion John Arnold John Arnold: Trump administration’s good effort on drug rebates is bad policy
Pharmalot Ed Silverman Pharmalittle: A Pfizer and Lilly painkiller misses study goals; LA County joins statewide effort to lower drug prices
Pharmalot Ed Silverman Vertex CEO says he will bring ‘new ideas’ to break a stalemate in the U.K. over a cystic fibrosis drug
Pharmalot Ed Silverman Lawmakers ask FDA to explain steps to contain contaminants in blood pressure drugs
Pharmalot Ed Silverman U.K. lawmaker challenges the government to issue a compulsory license for Vertex drug